505 related articles for article (PubMed ID: 19443047)
1. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
[TBL] [Abstract][Full Text] [Related]
2. Influence of oligoclonal IgM specificity in multiple sclerosis disease course.
Villar L; García-Barragán N; Espiño M; Roldán E; Sádaba M; Gómez-Rial J; González-Porqué P; Alvarez-Cermeño J
Mult Scler; 2008 Mar; 14(2):183-7. PubMed ID: 17942517
[TBL] [Abstract][Full Text] [Related]
3. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
4. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
5. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.
Villar LM; Masjuan J; Sádaba MC; González-Porqué P; Plaza J; Bootello A; Alvarez-Cermeño JC
Arch Neurol; 2005 Apr; 62(4):574-7. PubMed ID: 15824255
[TBL] [Abstract][Full Text] [Related]
6. Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands.
Bosca I; Villar LM; Coret F; Magraner MJ; Simó-Castelló M; Alvarez-Cermeño JC; Casanova B
Mult Scler; 2010 Jul; 16(7):810-5. PubMed ID: 20538705
[TBL] [Abstract][Full Text] [Related]
7. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.
Villar LM; Espiño M; Cavanillas ML; Roldán E; Urcelay E; de la Concha EG; Sádaba MC; Arroyo R; González-Porqué P; Alvarez-Cermeño JC
Clin Immunol; 2010 Oct; 137(1):51-9. PubMed ID: 20621566
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
Imrell K; Landtblom AM; Hillert J; Masterman T
Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
[TBL] [Abstract][Full Text] [Related]
9. Oligoclonal bands measured in unconcentrated cerebrospinal fluid and other biochemical parameters in multiple sclerosis.
Kurzepa J; Nastaj M; Mitosek-Szewczyk K; Bartosik-Psujek H; Stelmasiak Z
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):392-6. PubMed ID: 16146115
[TBL] [Abstract][Full Text] [Related]
10. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes.
Magraner MJ; Bosca I; Simó-Castelló M; García-Martí G; Alberich-Bayarri A; Coret F; Alvarez-Cermeño JC; Martí-Bonmatí L; Villar LM; Casanova B
Neuroradiology; 2012 Jan; 54(1):5-12. PubMed ID: 21327771
[TBL] [Abstract][Full Text] [Related]
11. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid.
Reiber H; Teut M; Pohl D; Rostasy KM; Hanefeld F
Mult Scler; 2009 Dec; 15(12):1466-80. PubMed ID: 19995844
[TBL] [Abstract][Full Text] [Related]
12. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
[TBL] [Abstract][Full Text] [Related]
13. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta.
Lundkvist M; Greiner E; Hillert J; Fogdell-Hahn A
Mult Scler; 2010 Jul; 16(7):796-800. PubMed ID: 20534645
[TBL] [Abstract][Full Text] [Related]
15. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.
Annunziata P; Giorgio A; De Santi L; Zipoli V; Portaccio E; Amato MP; Clerici R; Scarpini E; Moscato G; Iudice A; Vacca G; Orefice G; Morra VB; Maimone D
J Neurol Sci; 2006 May; 244(1-2):97-102. PubMed ID: 16473370
[TBL] [Abstract][Full Text] [Related]
16. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
Siritho S; Freedman MS
J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
[TBL] [Abstract][Full Text] [Related]
20. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.
Rot U; Mesec A
Clin Neurol Neurosurg; 2006 Mar; 108(3):271-4. PubMed ID: 16378679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
